Scholarly article on (E)-3-Methyl-4-(4-nitro-phenyl)-4-oxo-but-2-enoic acid 35584-79-3 from Journal of the Chemical Society B: Physical Organic p. 156,157-159

DOI: 10.1039/j29710000156

Source and publish data:

Journal of the Chemical Society B: Physical Organic p. 156,157-159 (1971)

Update date:2022-08-04

Topics:

Authors:

Bowden Bowden

Henry Henry

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1039/j29710000156

Full text of DOI:10.1039/j29710000156

View Article Online / Journal Homepage / Table of Contents for this issue

View Article Online

Products guided by the article

Product name:(E)-3-Methyl-4-(4-nitro-phenyl)-4-oxo-but-2-enoic acid

Cas No:35584-79-3

R&D Labs maybe for 35584-79-3

JIANGXI AIFEIMU TECHNOLOGY CO.，LTD

Contact:+86-570-6040289

Address:FINECHEMICAL PARK,ZIBU TOWN,WANNIAN COUNTY,JIANGXI PROV.,CHINA,ZIP
BrightGene Bio-Medical Technology Co., Ltd.

website:https://en.bright-gene.com/

Contact:+86-512-62551801

Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
NANCHANG QINZHI SCI&TEC.CO.,LTD(expird)

Contact:+86-13687004106

Address:Hero South Road,Hero Zone,Nanchang,Jiangxi,China
Shanghai PotentPharm Science and Technology Co.,Ltd

Contact:86-021-51969655

Address:Unit B, Building 18, No.300, Chuantu Rd,Pudong District, Shanghai 201202, China
Chengdu NoVi Biotechnology Co., Ltd.(expird)

Contact:13551243286/028-81458053

Address:NO.168-1-224 JULONG ROAD WUHOU DISTRICT, CHENGDU CITY,SICHUAN PROVINCE

Relevant to this article

Doi:10.1055/s-1973-22172
(1973)
Solution phase synthesis of β-peptides using micro reactors

Doi:10.1016/S0040-4020(02)00513-6
(2002)
A conformationally programmable ligand [21]

Doi:10.1021/ja0158713
(2001)
Doi:10.1021/ja01591a059
(1956)
An Acid-Catalyzed Epoxide Ring-Opening/Transesterification Cascade Cyclization to Diastereoselective Syntheses of (±)-β-Noscapine and (±)-β-Hydrastine

Doi:10.1021/acs.orglett.9b02715
(2019)
Design, synthesis, and biological evaluation studies of novel quinazolinone derivatives as anticonvulsant agents

Doi:10.1007/s00044-013-0569-5
(2013)

Article Doi

DOI: 10.1039/j29710000156